April 24, 2014 1:27 PM ET

Healthcare Equipment and Supplies

Company Overview of Oxford Immunotec Global PLC

Company Overview

Oxford Immunotec Global PLC, a diagnostics company, focuses on the provision of various tests in the field of immunology in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

94C Innovation Drive

Milton Park

Abingdon,  OX14 4RZ

United Kingdom

Founded in 2002

157 Employees

Phone:

44 1235 442780

Key Executives for Oxford Immunotec Global PLC

Chief Executive Officer and Director
Age: 39
Total Annual Compensation: $303.4K
Chief Financial Officer and Principal Accounting Officer
Age: 53
Total Annual Compensation: $225.5K
Chief Commercial Officer
Age: 52
Total Annual Compensation: $272.7K
Compensation as of Fiscal Year 2012.

Oxford Immunotec Global PLC Key Developments

Oxford Immunotec Global PLC Announces Unaudited Consolidated Earnings Results for Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for First Quarter and Full Year of 2014

Oxford Immunotec Global PLC announced unaudited consolidated earnings results for fourth quarter and full year ended December 31, 2013. For the quarter, the company reported revenues were $10.2 million, representing 94% growth over 2012 fourth quarter revenues of $5.3 million. LBITDA was $2.7 million compared to $4.2 million in the fourth quarter of 2012. Adjusted LBITDA was $1.4 million compared to $4.1 million in the same period in 2012. EBITDA and Adjusted EBTIDA are non-GAAP financial measures. Net loss was $3.3 million or $0.38 per share compared to $4.3 million or $1.99 per share in the fourth quarter of 2012. Loss before income taxes was $3,271,000 compared to $4,462,000 for the same period last year. For the year, the company reported revenues were $38.8 million, an increase of $18.1 million over 2012 full year revenues of $20.7 million. LBITDA for 2013 was $6.8 million compared to $12.7 million in 2012. Adjusted LBITDA was $5.7 million compared to $12.1 million in the prior year. Net loss was $8.7 million or $2.26 per share in comparison to a $14.9 million net loss or $8.44 per share for full year 2012. Loss before income taxes was $8,572,000 compared to $15,034,000 for the same period last year. For the first quarter of 2014, the company expects to report revenues of between $11.4 and $11.9 million. For the full year 2014, the company expects to report revenues of between $47 and $50 million.

Oxford Immunotec Global PLC Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 02:40 PM

Oxford Immunotec Global PLC Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 02:40 PM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Mark Klausner, Investor Relations, Peter Wrighton-Smith, Chief Executive Officer and Director, Richard M. Altieri, Chief Financial Officer and Principal Accounting Officer.

Oxford Immunotec Global PLC Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-05-2014 11:20 AM

Oxford Immunotec Global PLC Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-05-2014 11:20 AM. Venue: Marriott Copley Place Hotel, Boston, Massachusetts, United States.

Similar Private Companies By Industry

Company Name Region
KCI Medical Ltd. Europe
Penlon Limited Europe
Freedom Enterprises (2004) Ltd. Europe
Prism UK Medical Ltd. Europe
Owen Mumford Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford Immunotec Global PLC, please visit www.oxfordimmunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.